More on FATE
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.38 |
|
|||
| Open | $1.34 | ||||
| 52 Wk High | $4.76 | ||||
| 52 Wk Low | $1.46 | ||||
| Day High | $1.37 | ||||
| Day Low | $1.26 | ||||
| P/E | N/A | ||||
| EPS | $-1.91 | ||||
| Volume | 1,762,723 | ||||
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
- Baird on Fate Therapeutics (FATE): 'Incrementally positive on FT819 enrollment ramp and early FT836 clinical data'
- Form 10-K FATE THERAPEUTICS INC For: Dec 31
- Form 8-K FATE THERAPEUTICS INC For: Feb 26
- Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
- Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Breaking Barriers: How 2026’s Top Clinical Leaders Are Disrupting Chronic Disease Markets
- Form 4 FATE THERAPEUTICS INC For: Jan 15 Filed by: TAHL CINDY
- Form 4 FATE THERAPEUTICS INC For: Jan 15 Filed by: Adawi Kamal
Entities mentioned with FATE
- FDA | View Related Stories »
- Earnings | View Related Stories »
- S3 | View Related Stories »
- Jefferies & Co | View Related Stories »
- 13G | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Wells Fargo | View Related Stories »
- Show More...
